Sanjeev Kumar has joined on 1st August 2026 at Vivosure Essentials Pvt. Ltd. as Co-founder & Chief Sales Officer, effective 1 August 2026. A key arm of VivoCorp India, Vivosure Essentials has brought the accomplished healthcare leader on board to strengthen its leadership team and drive the company’s next phase of growth. With more than 20 years of experience across the pharmaceutical, surgical, and medical device sectors, Sanjeev brings extensive expertise in government engagement, institutional partnerships, market access, and commercial leadership.
Throughout his career, Sanjeev has built a strong track record in the diabetes care segment, successfully leading initiatives across government and institutional business, tender operations, and market access. His experience across multinational pharmaceutical and medical device organizations has equipped him with a deep understanding of India’s evolving healthcare landscape.
Sanjeev has led high-performing teams across Delhi NCR, Rajasthan, Punjab, Madhya Pradesh, and Chhattisgarh, while spending nearly nine years managing business across Delhi NCR’s corporate hospitals. He also held national responsibility for Tender & Access and was part of the core launch team that introduced GLP-1 therapy in the Delhi-Haryana market. Recognized for combining commercial excellence with a people-first leadership approach, he has consistently delivered impactful business outcomes throughout his career.
In his new role, Sanjeev will lead Government & Institutional Business at Vivosure Essentials, focusing on strengthening the company’s position within the VivoCorp India group and the broader public healthcare ecosystem. His responsibilities will include expanding opportunities through the Government e-Marketplace (GeM), institutional sales, market access, and Health Economics & Outcomes Research (HEOR). With Sanjeev’s proven leadership and extensive industry expertise, Vivosure Essentials is well-positioned to accelerate innovation and drive sustainable growth as VivoCorp India continues to expand its footprint in the healthcare sector.